Skip to content

Clinical trials

Phase 4 Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 4 Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20051
20066
20075
20084
20096
20104
20116
20124
20131
20147
20153
20164
20172
20181
20193
20211
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated16
Unknown status7
Recruiting3
Withdrawn3
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics6
Actelion3
Washington University School of Medicine3
Bayer2
Duke University2
Hospital Clinic of Barcelona2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Stanford University2
University of California, Los Angeles2
University of Pennsylvania2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary68
Pulmonary Arterial Hypertension14
Lung Diseases, Interstitial4
Pulmonary Disease, Chronic Obstructive4
Altitude Sickness3
Aortic Valve Stenosis3
Heart Failure3
Connective Tissue Diseases2
Heart Defects, Congenital2
Heart Failure, Diastolic2

Trials

Showing 26 to 50 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.